Skip to main content
RBOT logo

RBOT · Vicarious Surgical Inc. · Webcasts, Transcripts & Audio

Track RBOT — free
$0.90 At close · Mar 4
Market Cap
$284,969
Shares
7.12M
Volume · Mar 4 334.8K Avg daily vol (3M) 144.18K

Vicarious Surgical Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Vicarious Surgical Inc. (RBOT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY25 · Q4
2026-03-09
Vicarious Surgical Inc. (RBOT) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript
Cautious tone Cost Reduction and Cash Burn Outsourcing and Consulting Engagement Clinical Testing and Surgeon Feedback
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript
Balanced tone Leadership Transition System Readiness / Verification Capital Strategy
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript
Positive tone System build-out and preclinical testing Clinical milestones and first patients Financial position and cash runway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
Vicarious Surgical Inc. (RBOT) Q4 2024 Earnings Call Transcript
Positive tone First Clinical Patients / Regulatory Pathway V1.0 System Integration & Cadaver Lab Hospital System Partnerships
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Positive tone Clinical and regulatory pathway Single-port robotic system development Financial discipline and cost management
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Vicarious Surgical Inc. (RBOT) Q2 2024 Earnings Call Transcript
Positive tone Financial Performance and Cash Runway Regulatory and Clinical Trial Strategy Hospital Partnerships
Diluted EPS
$-2.59
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-29
Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript
Positive tone V1.0 System Development Expense Management / Capital Efficiency Regulatory Pathway (FDA & OUS)
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript
Cautious tone V1.0 System Development and Integration Capital Position and Financing Leadership Changes
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Vicarious Surgical Inc. (RBOT) Q2 2023 Earnings Call Transcript
Diluted EPS
$-3.62
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Vicarious Surgical Inc. (RBOT) Q1 2023 Earnings Call Transcript
Diluted EPS
$-6.30
▼ 163.6% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-13
Vicarious Surgical Inc. (RBOT) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Vicarious Surgical Inc. (RBOT) Q3 2022 Earnings Call Transcript
Diluted EPS
$-6.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Vicarious Surgical Inc. (RBOT) Q2 2022 Earnings Call Transcript
Diluted EPS
$-0.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Vicarious Surgical Inc. (RBOT) Q1 2022 Earnings Call Transcript
Diluted EPS
$9.90
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Vicarious Surgical Inc. (RBOT) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Vicarious Surgical Inc. (RBOT) Q3 2021 Earnings Call Transcript
Diluted EPS
$-14.70
Audio Transcript Slides 8-K10-Q
Showing 1–18 of 18 webcasts
Key facts CIK 1812173 CUSIP 92561V208 Visit website Investor relations